Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application.
Tissue engineering is an increasingly expanding area of research in the cardiovascular field that involves engineering, chemistry, biology and medicine. Cardiac tissue engineering (CTE) aims to regenerate myocardial damage by combining cells, matrix, biological active molecules and physiological stimuli. The rationale behind CTE applications is that in order to regenerate the ventricular wall after a myocardial infarction it is necessary to combine procedures that regenerate both cardiomyocytes and the extracellular matrix. The application of (stem) cells together with a matrix could represent an environment protected from the inflammatory and pro-apoptotic signals, a stemness/survival reservoir slowly releasing cells and factors promoting tissue regeneration and angiogenesis. This review will focus on the applications and advantages that CTE application could offer compared to conventional cell therapy.
Gaetani
Roberto
R
Department of Experimental Medicine, Cenci-Bolognetti Foundation, Pasteur Institute, University of Rome Sapienza, Rome, Italy. R.Gaetani@umcutrecht.nl
Rizzitelli
Giuseppe
G
Chimenti
Isotta
I
Barile
Lucio
L
Forte
Elvira
E
Ionta
Vittoria
V
Angelini
Francesco
F
Sluijter
Joost P G
JP
Barbetta
Andrea
A
Messina
Elisa
E
Frati
Giacomo
G
D006801:Humans; D009206:Myocardium / Q000166:cytology* / Q000378:metabolism*; D012038:Regeneration / Q000502:physiology*; D018874:Spheroids, Cellular / Q000166:cytology* / Q000378:metabolism; D033581:Stem Cell Transplantation; D023822:Tissue Engineering / Q000379:methods*
J Am Coll Cardiol. 2005 Aug 16;46(4):714-9
16098441
J Am Coll Cardiol. 2009 Oct 20;54(17):1619-26
19833262
Cell Transplant. 2002;11(7):621-30
12518889
Circulation. 2007 Feb 20;115(7):896-908
17283259
Nat Med. 2006 Apr;12(4):452-8
16582915
Nat Protoc. 2009;4(2):232-43
19197267
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8155-60
16698918
Cardiovasc Hematol Agents Med Chem. 2009 Apr;7(2):91-107
19355872
Cell Transplant. 2009;18(3):297-304
19558778
Neth Heart J. 2008 May;16(5):163-9
18566670
Circulation. 2008 Mar 18;117(11):1388-96
18316487
J Clin Invest. 2006 Jan;116(1):237-48
16357943
Cell Transplant. 2007;16(9):927-34
18293891
J Thorac Cardiovasc Surg. 2009 Jan;137(1):180-7
19154923
Circ Res. 2004 Oct 29;95(9):911-21
15472116
J Mol Cell Cardiol. 2008 Oct;45(4):567-81
18466917
Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):240-9
19234502
Circulation. 2009 Sep 8;120(10):876-87
19704095
J Mol Cell Cardiol. 2006 Nov;41(5):876-84
16973174
Circ Res. 2010 Mar 19;106(5):971-80
20110532
Tissue Eng. 2005 May-Jun;11(5-6):803-13
15998220
Biomacromolecules. 2009 Dec 14;10(12):3188-92
19891500
J Am Coll Cardiol. 2004 Aug 4;44(3):654-60
15358036
Cardiovasc Res. 2007 Jul 1;75(1):178-85
17481597
J Mol Cell Cardiol. 2001 May;33(5):907-21
11343414
Tissue Eng. 2003 Jun;9(3):517-23
12857419
Tissue Eng. 2005 Nov-Dec;11(11-12):1860-6
16411832
Tissue Eng. 2007 Nov;13(11):2681-7
17691866
Circulation. 2006 Jul 4;114(1 Suppl):I167-73
16820568
Circulation. 2005 Aug 30;112(9 Suppl):I150-6
16159808
Biomaterials. 2009 Oct;30(29):5409-16
19608268